Praxis Precision Total Debt vs. Cash And Equivalents

PRAX Stock  USD 74.20  2.09  2.90%   
Considering Praxis Precision's profitability and operating efficiency indicators, Praxis Precision Medicines may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Praxis Precision's ability to earn profits and add value for shareholders.
For Praxis Precision profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Praxis Precision to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Praxis Precision Medicines utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Praxis Precision's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Praxis Precision Medicines over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Praxis Precision. If investors know Praxis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Praxis Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Praxis Precision Med is measured differently than its book value, which is the value of Praxis that is recorded on the company's balance sheet. Investors also form their own opinion of Praxis Precision's value that differs from its market value or its book value, called intrinsic value, which is Praxis Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Praxis Precision's market value can be influenced by many factors that don't directly affect Praxis Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Praxis Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Praxis Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Praxis Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Praxis Precision Med Cash And Equivalents vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Praxis Precision's current stock value. Our valuation model uses many indicators to compare Praxis Precision value to that of its competitors to determine the firm's financial worth.
Praxis Precision Medicines is rated below average in total debt category among its peers. It is rated below average in cash and equivalents category among its peers creating about  66.29  of Cash And Equivalents per Total Debt. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Praxis Precision's earnings, one of the primary drivers of an investment's value.

Praxis Total Debt vs. Competition

Praxis Precision Medicines is rated below average in total debt category among its peers. Total debt of Health Care industry is at this time estimated at about 258.14 Million. Praxis Precision maintains roughly 2.5 Million in total debt contributing less than 1% to equities under Health Care industry.
Total debt  Workforce  Revenue  Capitalization  Valuation

Praxis Cash And Equivalents vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Praxis Precision

Total Debt

 = 

Bonds

+

Notes

 = 
2.5 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Praxis Precision

Cash

 = 

Bank Deposits

+

Liquidities

 = 
165.4 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Praxis Cash And Equivalents Comparison

Praxis Precision is currently under evaluation in cash and equivalents category among its peers.

Praxis Precision Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Praxis Precision, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Praxis Precision will eventually generate negative long term returns. The profitability progress is the general direction of Praxis Precision's change in net profit over the period of time. It can combine multiple indicators of Praxis Precision, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company was incorporated in 2015 and is based in Boston, Massachusetts. Praxis Precision operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1 people.

Praxis Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Praxis Precision. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Praxis Precision position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Praxis Precision's important profitability drivers and their relationship over time.

Use Praxis Precision in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Praxis Precision position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Praxis Precision will appreciate offsetting losses from the drop in the long position's value.

Praxis Precision Pair Trading

Praxis Precision Medicines Pair Trading Analysis

The ability to find closely correlated positions to Praxis Precision could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Praxis Precision when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Praxis Precision - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Praxis Precision Medicines to buy it.
The correlation of Praxis Precision is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Praxis Precision moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Praxis Precision Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Praxis Precision can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Praxis Precision position

In addition to having Praxis Precision in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Macroaxis Index Thematic Idea Now

Macroaxis Index
Macroaxis Index Theme
An experimental equal-weighted index theme of selected equities generated based on Macroaxis rating and scoring system. The Macroaxis Index theme has 52 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Index Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Praxis Stock Analysis

When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.